Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia

American Journal of Psychiatry

Volumn 159, Issue 3, 2002, Pages 480-482

  Heresco Levy, Uriel ^a   Ermilov, Marina ^a   Shimoni, Jonathan ^a   Shapira, Baruch ^a   Silipo, Gail ^a   Javitt, Daniel C ^a  

^a HERZOG HOSPITAL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSERINE; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; RISPERIDONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; NEGATIVE SYNDROME; PRIORITY JOURNAL; SCHIZOPHRENIA; SCORING SYSTEM; STATISTICAL ANALYSIS; VARIANCE;

EID: 0036184549     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.159.3.480     Document Type: Article

References (12)

1. Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia
2. D-Serine added to antipsychotics for the treatment of enduring negative symptoms of schizophrenia
3. Placebo-controlled trial of glycine added to clozapine in schizophrenia
4. D-Serine added to clozapine for the treatment of schizophrenia
5. Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia
6. A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia
7. Double-blind, placebo-controlled, crossover trial of D-cycloserine adjuvant therapy for treatment-resistant schizophrenia
8. D-cycloserine added to clozapine for patients with schizophrenia
9. A placebo-controlled crossover trial of D-Cycloserine added to clozapine in patients with schizophrenia
10. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
11. A rating scale for extrapyramidal side effects